2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with myricetin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alink, GM; Groten, JP; Rietjens, IM; Schutte, ME; van de Sandt, JJ | 1 |
| Akhtar, S; Anderson, D; Gopalan, RC; Isreb, M; Najafzadeh, M; Newton, L | 1 |
| Akhtar, S; Anderson, D; Azam, TM; Malik, A | 1 |
3 other study(ies) available for 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and myricetin
| Article | Year |
|---|---|
Myricetin stimulates the absorption of the pro-carcinogen PhIP.
Topics: Absorption; ATP-Binding Cassette Transporters; Caco-2 Cells; Carcinogens; Flavonoids; Humans; Imidazoles; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Permeability | 2006 |
Ex vivo/in vitro protective effect of myricetin bulk and nano-forms on PhIP-induced DNA damage in lymphocytes from healthy individuals and pre-cancerous MGUS patients.
Topics: Adult; Aged; Aged, 80 and over; Antimutagenic Agents; Antioxidants; Ataxia Telangiectasia Mutated Proteins; Case-Control Studies; Cells, Cultured; Comet Assay; DNA Damage; Female; Flavonoids; Humans; Imidazoles; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Mutagens; Nanoparticles; Oxidative Stress; Signal Transduction; Tumor Suppressor Protein p53; Young Adult | 2020 |
P53-mediated in vitro inhibition of PhIP-induced oxidative damage by myricetin bulk and nano forms in healthy lymphocytes.
Topics: Animals; Flavonoids; Humans; Imidazoles; Lymphocytes; Oxidative Stress; Tumor Suppressor Protein p53 | 2021 |